Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical dapsone 5% vs topical clindamycin 1% in mild to moderate acne vulgaris
IRCT20250124064503N1Phase 3Completed
- Sponsor
- Khawaja Muhammad Safdar Medical College
- Start
- Feb 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dapsone and clindamycin in acne vulgaris (2 arms), sponsored by Khawaja Muhammad Safdar Medical College. Started Feb 2025; status: completed.
02
Drugs
dapsoneclindamycin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on IRCT20250124064503N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250124064503N1.